510(k) K232202— Aperio GT 450 DX

Substantially Equivalent

Leica Biosystems Imaging, Inc.

Clearance details

Applicant: Leica Biosystems Imaging, Inc.
Product code: Code PSY
Advisory panel: Pathology
Date received: 2023-07-25
Decision date: 2024-04-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Vista, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.